Report Detail

Request for Sample of this report

Pharma & Healthcare Global Afatinib API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4751930
    • |
  • 05 October, 2026
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Afatinib API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Afatinib is an Active Pharmaceutical Ingredient (API) that serves as a selective, irreversible tyrosine kinase inhibitor used in cancer therapy. It is primarily indicated for the treatment of advanced non-small cell lung cancer with specific genetic mutations in the epidermal growth factor receptor (EGFR) gene.
This report is a detailed and comprehensive analysis for global Afatinib API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Afatinib API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Afatinib API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Afatinib API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Afatinib API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Afatinib API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Afatinib API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shandong Anhong Pharmaceutical, Lianyungang Runzhong Pharmaceutical, Jiangsu Xidi Pharmaceuticals, Jiangsu Tasly Diyi Pharmaceutical, Fresenius Kabi, Shilpa Medicare, Clearsynth Labs, MSN Laboratories, Hetero Labs, Alembic Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Afatinib API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99%
Market segment by Application
Online Sales
Offline Sales
Major players covered
Shandong Anhong Pharmaceutical
Lianyungang Runzhong Pharmaceutical
Jiangsu Xidi Pharmaceuticals
Jiangsu Tasly Diyi Pharmaceutical
Fresenius Kabi
Shilpa Medicare
Clearsynth Labs
MSN Laboratories
Hetero Labs
Alembic Pharmaceuticals
Lotus International
Caplin Point Laboratories
Rmpl Pharma LLP
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Afatinib API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Afatinib API, with price, sales quantity, revenue, and global market share of Afatinib API from 2021 to 2026.
Chapter 3, the Afatinib API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Afatinib API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Afatinib API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Afatinib API.
Chapter 14 and 15, to describe Afatinib API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Afatinib API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Afatinib API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Afatinib API Market Size & Forecast
    • 1.5.1 Global Afatinib API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Afatinib API Sales Quantity (2021-2032)
    • 1.5.3 Global Afatinib API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Shandong Anhong Pharmaceutical
    • 2.1.1 Shandong Anhong Pharmaceutical Details
    • 2.1.2 Shandong Anhong Pharmaceutical Major Business
    • 2.1.3 Shandong Anhong Pharmaceutical Afatinib API Product and Services
    • 2.1.4 Shandong Anhong Pharmaceutical Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Shandong Anhong Pharmaceutical Recent Developments/Updates
  • 2.2 Lianyungang Runzhong Pharmaceutical
    • 2.2.1 Lianyungang Runzhong Pharmaceutical Details
    • 2.2.2 Lianyungang Runzhong Pharmaceutical Major Business
    • 2.2.3 Lianyungang Runzhong Pharmaceutical Afatinib API Product and Services
    • 2.2.4 Lianyungang Runzhong Pharmaceutical Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
  • 2.3 Jiangsu Xidi Pharmaceuticals
    • 2.3.1 Jiangsu Xidi Pharmaceuticals Details
    • 2.3.2 Jiangsu Xidi Pharmaceuticals Major Business
    • 2.3.3 Jiangsu Xidi Pharmaceuticals Afatinib API Product and Services
    • 2.3.4 Jiangsu Xidi Pharmaceuticals Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Jiangsu Xidi Pharmaceuticals Recent Developments/Updates
  • 2.4 Jiangsu Tasly Diyi Pharmaceutical
    • 2.4.1 Jiangsu Tasly Diyi Pharmaceutical Details
    • 2.4.2 Jiangsu Tasly Diyi Pharmaceutical Major Business
    • 2.4.3 Jiangsu Tasly Diyi Pharmaceutical Afatinib API Product and Services
    • 2.4.4 Jiangsu Tasly Diyi Pharmaceutical Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Jiangsu Tasly Diyi Pharmaceutical Recent Developments/Updates
  • 2.5 Fresenius Kabi
    • 2.5.1 Fresenius Kabi Details
    • 2.5.2 Fresenius Kabi Major Business
    • 2.5.3 Fresenius Kabi Afatinib API Product and Services
    • 2.5.4 Fresenius Kabi Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Fresenius Kabi Recent Developments/Updates
  • 2.6 Shilpa Medicare
    • 2.6.1 Shilpa Medicare Details
    • 2.6.2 Shilpa Medicare Major Business
    • 2.6.3 Shilpa Medicare Afatinib API Product and Services
    • 2.6.4 Shilpa Medicare Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Shilpa Medicare Recent Developments/Updates
  • 2.7 Clearsynth Labs
    • 2.7.1 Clearsynth Labs Details
    • 2.7.2 Clearsynth Labs Major Business
    • 2.7.3 Clearsynth Labs Afatinib API Product and Services
    • 2.7.4 Clearsynth Labs Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Clearsynth Labs Recent Developments/Updates
  • 2.8 MSN Laboratories
    • 2.8.1 MSN Laboratories Details
    • 2.8.2 MSN Laboratories Major Business
    • 2.8.3 MSN Laboratories Afatinib API Product and Services
    • 2.8.4 MSN Laboratories Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 MSN Laboratories Recent Developments/Updates
  • 2.9 Hetero Labs
    • 2.9.1 Hetero Labs Details
    • 2.9.2 Hetero Labs Major Business
    • 2.9.3 Hetero Labs Afatinib API Product and Services
    • 2.9.4 Hetero Labs Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hetero Labs Recent Developments/Updates
  • 2.10 Alembic Pharmaceuticals
    • 2.10.1 Alembic Pharmaceuticals Details
    • 2.10.2 Alembic Pharmaceuticals Major Business
    • 2.10.3 Alembic Pharmaceuticals Afatinib API Product and Services
    • 2.10.4 Alembic Pharmaceuticals Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Alembic Pharmaceuticals Recent Developments/Updates
  • 2.11 Lotus International
    • 2.11.1 Lotus International Details
    • 2.11.2 Lotus International Major Business
    • 2.11.3 Lotus International Afatinib API Product and Services
    • 2.11.4 Lotus International Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Lotus International Recent Developments/Updates
  • 2.12 Caplin Point Laboratories
    • 2.12.1 Caplin Point Laboratories Details
    • 2.12.2 Caplin Point Laboratories Major Business
    • 2.12.3 Caplin Point Laboratories Afatinib API Product and Services
    • 2.12.4 Caplin Point Laboratories Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Caplin Point Laboratories Recent Developments/Updates
  • 2.13 Rmpl Pharma LLP
    • 2.13.1 Rmpl Pharma LLP Details
    • 2.13.2 Rmpl Pharma LLP Major Business
    • 2.13.3 Rmpl Pharma LLP Afatinib API Product and Services
    • 2.13.4 Rmpl Pharma LLP Afatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Rmpl Pharma LLP Recent Developments/Updates

3 Competitive Environment: Afatinib API by Manufacturer

  • 3.1 Global Afatinib API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Afatinib API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Afatinib API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Afatinib API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Afatinib API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Afatinib API Manufacturer Market Share in 2025
  • 3.5 Afatinib API Market: Overall Company Footprint Analysis
    • 3.5.1 Afatinib API Market: Region Footprint
    • 3.5.2 Afatinib API Market: Company Product Type Footprint
    • 3.5.3 Afatinib API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Afatinib API Market Size by Region
    • 4.1.1 Global Afatinib API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Afatinib API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Afatinib API Average Price by Region (2021-2032)
  • 4.2 North America Afatinib API Consumption Value (2021-2032)
  • 4.3 Europe Afatinib API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Afatinib API Consumption Value (2021-2032)
  • 4.5 South America Afatinib API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Afatinib API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Afatinib API Sales Quantity by Type (2021-2032)
  • 5.2 Global Afatinib API Consumption Value by Type (2021-2032)
  • 5.3 Global Afatinib API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Afatinib API Sales Quantity by Application (2021-2032)
  • 6.2 Global Afatinib API Consumption Value by Application (2021-2032)
  • 6.3 Global Afatinib API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Afatinib API Sales Quantity by Type (2021-2032)
  • 7.2 North America Afatinib API Sales Quantity by Application (2021-2032)
  • 7.3 North America Afatinib API Market Size by Country
    • 7.3.1 North America Afatinib API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Afatinib API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Afatinib API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Afatinib API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Afatinib API Market Size by Country
    • 8.3.1 Europe Afatinib API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Afatinib API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Afatinib API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Afatinib API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Afatinib API Market Size by Region
    • 9.3.1 Asia-Pacific Afatinib API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Afatinib API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Afatinib API Sales Quantity by Type (2021-2032)
  • 10.2 South America Afatinib API Sales Quantity by Application (2021-2032)
  • 10.3 South America Afatinib API Market Size by Country
    • 10.3.1 South America Afatinib API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Afatinib API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Afatinib API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Afatinib API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Afatinib API Market Size by Country
    • 11.3.1 Middle East & Africa Afatinib API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Afatinib API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Afatinib API Market Drivers
  • 12.2 Afatinib API Market Restraints
  • 12.3 Afatinib API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Afatinib API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Afatinib API
  • 13.3 Afatinib API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Afatinib API Typical Distributors
  • 14.3 Afatinib API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Afatinib API. Industry analysis & Market Report on Afatinib API is a syndicated market report, published as Global Afatinib API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Afatinib API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo